What the research found

Researchers identified a mechanistic link between NAD+ availability and the length of primary cilia on hypothalamic neurons—structures that cells use to sense and respond to their environment. When NAD+ levels drop (either with age or experimentally), cilia shorten; raising NAD+ through supplementation or caloric restriction lengthens them again. This relationship appears causal, demonstrated through multiple approaches: depleting NAD+ in cultured neurons shortened cilia, while boosting it lengthened them.

The mechanism involves SIRT1, an NAD+-dependent protein. SIRT1 acts as a deacetylase to activate genes controlling ciliary growth, particularly by enhancing a factor called RFX1. The cilia themselves appear to play an active role in autophagy—the cellular cleanup process—by positioning a protein called CHMP4B to maintain lysosomal integrity. When NAD+ drops, CHMP4B abandons the cilia and relocates to lysosomes, impairing their function.

Crucially, when researchers blocked ciliary growth genes in aged mice undergoing caloric restriction, the metabolic benefits of that restriction disappeared—suggesting the cilia are not merely correlated with but fundamentally required for caloric restriction's anti-aging effects.

Why it matters for you

If you're using NAD+ precursors (NMN, NR) or practicing caloric restriction, this research suggests those interventions may work partly through a very specific pathway: maintaining healthy cilia on your hypothalamic neurons, which in turn preserve autophagy and metabolic control. The hypothalamus is your body's metabolic command center, regulating energy expenditure, appetite, and glucose handling—all things MyKine users monitor through weight, fasting glucose, and insulin sensitivity.

The link to autophagy is particularly relevant if you track longevity markers or use peptides and supplements designed to enhance cellular cleaning. This work implies NAD+-raising strategies may support that process via ciliary function. For those combining caloric restriction or time-restricted eating with NAD+ supplementation, the two appear to converge on the same pathway, though neither alone may capture the full effect if ciliary function is compromised.

That said, this is foundational science on how an intervention might work—not a guide to optimizing your protocol. It doesn't yet tell you whether ciliary length itself is measurable in humans, or whether the effect size justifies specific dosing choices.

Caveats

• Work is primarily in mice; translation to human hypothalamic physiology is unconfirmed
• Most mechanistic detail comes from in vitro (cultured neuron) experiments, which may not reflect in vivo conditions
• The final proof-of-concept experiment used gene silencing in one aged cohort; generalisation to diverse populations and ages unclear
• No data on whether measuring or optimising ciliary length in humans is feasible or clinically useful
• Early-stage; the authors themselves call for further confirmation before clinical applications